• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

曲霉特异性 IgG 抗体检测在诊断非中性粒细胞减少性侵袭性肺曲霉病中的临床价值。

The clinical value of Aspergillus-specific IgG antibody test in the diagnosis of nonneutropenic invasive pulmonary aspergillosis.

机构信息

Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China; Department of Respiratory and Critical Care Medicine, Jinling Hospital, Medical School of Nanjing University, Nanjing, China.

Department of Respiratory and Critical Care Medicine, Jinling Hospital, Medical School of Nanjing University, Nanjing, China.

出版信息

Clin Microbiol Infect. 2023 Jun;29(6):797.e1-797.e7. doi: 10.1016/j.cmi.2023.02.002. Epub 2023 Feb 10.

DOI:10.1016/j.cmi.2023.02.002
PMID:
36773771
Abstract

OBJECTIVES

Aspergillus-specific IgG antibody (Asp IgG) has been successfully applied in the diagnosis of chronic pulmonary aspergillosis. We explored its value in nonneutropenic invasive pulmonary aspergillosis (IPA) by a multicenter, prospective, and controlled study.

METHODS

We enrolled 372 clinically suspected nonneutropenic patients with IPA from February 2015 to August 2022. After excluding 4 cases with Aspergillus colonization, the remaining 368 cases were finally confirmed as patients with IPA (n = 99), or non-IPA patients (n = 269) consisting of community-acquired pneumonia (n = 206), tuberculosis (n = 22), nontuberculous mycobacteria (n = 5), lung abscess (n = 6), or noninfectious diseases (n = 30). Asp IgG in plasma samples was tested by enzyme-linked immunosorbent assay.

RESULTS

At cut-off value of ≥80 AU/mL, Asp IgG had much higher sensitivity (59.6% vs. 19.2%, p < 0.0001), but lower specificity (77.0% vs. 96.3%, p < 0.0001) than serum galactomannan (GM) (cut-off value of ≥1.0), and similar sensitivity (59.6% vs. 55.6%, p = 0.611) but lower specificity (77.0% vs. 91.2%, p = 0.001) than bronchoalveolar lavage fluid (BALF) GM (cut-off value of ≥1.0), respectively. Combination diagnosis of either positive for Asp IgG or BALF GM had higher sensitivity (81.0% vs. 55.6%, p = 0.002), but lower specificity (75.2% vs. 91.2%, p = 0.001) than BALF GM alone. The receiver operating characteristic curve showed that Asp IgG had an optimal diagnostic value when the cut-off value was 56.6 AU/ml, and the sensitivity and specificity were 77.8% and 63.9%, respectively.

DISCUSSIONS

The diagnostic value of Asp IgG for IPA is superior to serum GM, and a little inferior to BALF GM in nonneutropenic patients with IPA. Considering the convenience of taking blood samples, it is a good screening and diagnostic method for nonneutropenic patients with IPA, especially for those who cannot bear invasive procedures.

摘要

目的

曲霉特异性 IgG 抗体(Asp IgG)已成功应用于慢性肺曲霉病的诊断。我们通过多中心、前瞻性、对照研究探讨了其在非中性粒细胞性侵袭性肺曲霉病(IPA)中的价值。

方法

我们纳入了 2015 年 2 月至 2022 年 8 月期间 372 例临床疑似非中性粒细胞性 IPA 患者。排除 4 例曲霉定植后,最终确定 368 例患者为 IPA(n=99)或非 IPA 患者(n=269),包括社区获得性肺炎(n=206)、肺结核(n=22)、非结核分枝杆菌(n=5)、肺脓肿(n=6)或非传染性疾病(n=30)。采用酶联免疫吸附试验检测血浆样本中的 Asp IgG。

结果

在≥80 AU/ml 截断值时,Asp IgG 的敏感性(59.6%比 19.2%,p<0.0001)高于血清半乳甘露聚糖(GM)(≥1.0),但特异性(77.0%比 96.3%,p<0.0001)较低;与支气管肺泡灌洗液(BALF)GM(≥1.0)相比,敏感性(59.6%比 55.6%,p=0.611)相似,特异性(77.0%比 91.2%,p=0.001)较低。Asp IgG 或 BALF GM 联合诊断的敏感性(81.0%比 55.6%,p=0.002)较高,特异性(75.2%比 91.2%,p=0.001)较低。受试者工作特征曲线显示,当截断值为 56.6 AU/ml 时,Asp IgG 的诊断价值最佳,敏感性和特异性分别为 77.8%和 63.9%。

讨论

在非中性粒细胞性 IPA 患者中,Asp IgG 对 IPA 的诊断价值优于血清 GM,稍低于 BALF GM。考虑到采血的便利性,它是一种很好的非中性粒细胞性 IPA 患者的筛查和诊断方法,尤其是对那些不能耐受侵袭性操作的患者。

相似文献

1
The clinical value of Aspergillus-specific IgG antibody test in the diagnosis of nonneutropenic invasive pulmonary aspergillosis.曲霉特异性 IgG 抗体检测在诊断非中性粒细胞减少性侵袭性肺曲霉病中的临床价值。
Clin Microbiol Infect. 2023 Jun;29(6):797.e1-797.e7. doi: 10.1016/j.cmi.2023.02.002. Epub 2023 Feb 10.
2
Diagnostic Value of Galactomannan Antigen Test in Serum and Bronchoalveolar Lavage Fluid Samples from Patients with Nonneutropenic Invasive Pulmonary Aspergillosis.半乳甘露聚糖抗原检测在非中性粒细胞减少的侵袭性肺曲霉病患者血清和支气管肺泡灌洗样本中的诊断价值
J Clin Microbiol. 2017 Jul;55(7):2153-2161. doi: 10.1128/JCM.00345-17. Epub 2017 Apr 26.
3
Potential value of serum Aspergillus IgG antibody detection in the diagnosis of invasive and chronic pulmonary aspergillosis in non-agranulocytic patients.血清曲霉 IgG 抗体检测在诊断非粒细胞减少症患者侵袭性和慢性肺曲霉病中的潜在价值。
BMC Pulm Med. 2020 Apr 15;20(1):89. doi: 10.1186/s12890-020-1125-y.
4
[Galactomannan Tests of Bronchoalveolar Lavage Fluid for Diagnosing Invasive Pulmonary Aspergillosis].[支气管肺泡灌洗液体半乳甘露聚糖检测用于诊断侵袭性肺曲霉病]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2018 Jan;49(1):124-128.
5
[Diagnostic value of the combinations of bronchoalveolar lavage fluid galactomannan test and serum galactomannan test in invasive pulmonary aspergillosis].支气管肺泡灌洗术液半乳甘露聚糖检测与血清半乳甘露聚糖检测联合应用对侵袭性肺曲霉病的诊断价值
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019 Mar;31(3):331-335. doi: 10.3760/cma.j.issn.2095-4352.2019.03.014.
6
Role of galactomannan determinations in bronchoalveolar lavage fluid samples from critically ill patients with chronic obstructive pulmonary disease for the diagnosis of invasive pulmonary aspergillosis: a prospective study.半乳甘露聚糖检测在慢性阻塞性肺疾病重症患者支气管肺泡灌洗样本中对侵袭性肺曲霉病诊断的作用:一项前瞻性研究
Crit Care. 2012 Jul 27;16(4):R138. doi: 10.1186/cc11443.
7
[Evaluation of risk factors for invasive pulmonary aspergillosis and detection of diagnostic values of galactomannan and PCR methods in bronchoalveolar lavage samples from non-neutropenic intensive care unit patients].[非中性粒细胞减少的重症监护病房患者侵袭性肺曲霉病危险因素评估及支气管肺泡灌洗样本中半乳甘露聚糖和PCR方法诊断价值的检测]
Mikrobiyol Bul. 2015 Oct;49(4):565-75. doi: 10.5578/mb.9906.
8
[The diagnostic performance of galactomannan detection in invasive pulmonary aspergillosis with severe and critically ill influenza].[半乳甘露聚糖检测在重症及危重症流感合并侵袭性肺曲霉病中的诊断效能]
Zhonghua Yi Xue Za Zhi. 2021 Apr 20;101(15):1050-1056. doi: 10.3760/cma.j.cn112137-20200811-02337.
9
Bronchoalveolar lavage fluid galactomannan detection for diagnosis of invasive pulmonary aspergillosis in chronic obstructive pulmonary disease.支气管肺泡灌洗液半乳甘露聚糖检测对慢性阻塞性肺疾病侵袭性肺曲霉病的诊断价值。
Med Mycol. 2013 Oct;51(7):688-95. doi: 10.3109/13693786.2013.777162. Epub 2013 Mar 26.
10
Performance of the Euroimmun Aspergillus Antigen ELISA for the Diagnosis of Invasive Pulmonary Aspergillosis in Bronchoalveolar Lavage Fluid.Euroimmun 曲霉抗原 ELISA 在支气管肺泡灌洗液中诊断侵袭性肺曲霉病的性能。
J Clin Microbiol. 2022 Apr 20;60(4):e0021522. doi: 10.1128/jcm.00215-22. Epub 2022 Mar 30.

引用本文的文献

1
Evaluation of a novel aspergillus IgG lateral flow assay for the diagnosis of non-neutropenic patients with acute and subacute invasive aspergillosis.一种用于诊断非中性粒细胞减少患者急性和亚急性侵袭性曲霉病的新型曲霉IgG侧向流动检测法的评估。
Front Cell Infect Microbiol. 2025 Jun 20;15:1599425. doi: 10.3389/fcimb.2025.1599425. eCollection 2025.
2
Diagnosis of invasive pulmonary aspergillosis using metagenomic next-generation sequencing and conventional microbial tests post-COVID-19 pandemic.在新冠疫情后使用宏基因组下一代测序和传统微生物检测诊断侵袭性肺曲霉病
Microbiol Spectr. 2025 Jul;13(7):e0012125. doi: 10.1128/spectrum.00121-25. Epub 2025 Jun 9.
3
A Silent Threat in Post-Tuberculosis Patients: Chronic Pulmonary Aspergillosis Survey in Multiple Regions of Indonesia (I-CHROME Study).
肺结核后患者的隐匿威胁:印度尼西亚多个地区慢性肺曲霉病调查(I-CHROME研究)
J Fungi (Basel). 2025 Apr 22;11(5):329. doi: 10.3390/jof11050329.
4
Development and validation of a machine learning-based diagnostic model for identifying nonneutropenic invasive pulmonary aspergillosis in suspected patients: a multicenter cohort study.基于机器学习的诊断模型用于识别疑似患者非中性粒细胞减少性侵袭性肺曲霉病的开发与验证:一项多中心队列研究
Microbiol Spectr. 2025 Jul;13(7):e0060725. doi: 10.1128/spectrum.00607-25. Epub 2025 May 22.
5
Pentraxin-3 as a novel prognostic biomarker in non-neutropenic invasive pulmonary aspergillosis patients.Pentraxin-3作为非中性粒细胞减少的侵袭性肺曲霉病患者的一种新型预后生物标志物。
Microbiol Spectr. 2025 Mar 4;13(3):e0294524. doi: 10.1128/spectrum.02945-24. Epub 2025 Jan 29.
6
Development of a Prognostic Nomogram for Nonneutropenic Invasive Pulmonary Aspergillosis Based on Machine Learning.基于机器学习的非中性粒细胞减少侵袭性肺曲霉病预后列线图的开发
J Inflamm Res. 2024 Nov 26;17:9823-9835. doi: 10.2147/JIR.S499008. eCollection 2024.
7
Seroprevalence and prognostic value of Aspergillus-specific IgG among non-neutropenic invasive pulmonary aspergillosis patients: a prospective multicenter study.非中性粒细胞减少的侵袭性肺曲霉病患者中曲霉特异性IgG的血清流行率及预后价值:一项前瞻性多中心研究
Pneumonia (Nathan). 2024 Nov 5;16(1):28. doi: 10.1186/s41479-024-00154-8.
8
The value of metagenomic next-generation sequencing with different nucleic acid extracting methods of cell-free DNA or whole-cell DNA in the diagnosis of non-neutropenic pulmonary aspergillosis.不同核酸提取方法(细胞游离 DNA 或全细胞 DNA)的宏基因组二代测序在诊断非中性粒细胞减少性肺部曲霉病中的价值。
Front Cell Infect Microbiol. 2024 Jul 29;14:1398190. doi: 10.3389/fcimb.2024.1398190. eCollection 2024.
9
Value Evaluation of Quantitative -Specific IgG Antibody Test in the Diagnosis of Non-neutropenic Invasive Pulmonary Aspergillosis.定量特异性IgG抗体检测在非中性粒细胞减少侵袭性肺曲霉病诊断中的价值评估
Infect Drug Resist. 2024 May 23;17:2043-2052. doi: 10.2147/IDR.S460513. eCollection 2024.
10
Epidemiology and Azole Resistance of Clinical Isolates of from a Large Tertiary Hospital in Ningxia, China.中国宁夏某大型三级医院临床分离株的流行病学及唑类耐药性
Infect Drug Resist. 2024 Feb 2;17:427-439. doi: 10.2147/IDR.S440363. eCollection 2024.